Ampio Pharmaceuticals Profile

2.98
USD 0.04  1.32%
49%
52%

Exercise of in-the-money or at-the-money derivative position by Michael MacAluso of 27379 shares of Ampio Pharmaceuticals

Ampio Pharmaceuticals Inc insider trading alert for exercise of common stock by Michael MacAluso, Chief Executive Officer, on February 16, 2018. This event was filed by Ampio Pharmaceuticals Inc with SEC on 2013-11-27. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Ampio Pharmaceuticals Summary

Ampio Pharmaceuticals (AMPE) is traded on American Stock Exchange in USA. It is located in COLORADO, U.S.A and employs 17 people. Ampio Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 257.09 M. Ampio Pharmaceuticals conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 84.85 M outstanding shares of which 6.36 M shares are presently shorted by private and institutional investors with about 5.94 trading days to cover. AMPIO PHARMACEUTI currently holds about 8.22 M in cash with (11.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1.
Check Ampio Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 63.19%30 days 2.98  about 36.7%
Based on normal probability distribution, the odds of Ampio Pharmaceuticals to move above current price in 30 days from now is about 36.7% (This Ampio Pharmaceuticals probability density function shows the probability of Ampio Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Raymond James Financial Services Advisors IncCommon Shares63.9 K217 K
Creative PlanningCommon Shares26 K88 K
Susquehanna International Group LlpPut Options228.7 K930 K
Susquehanna International Group LlpCall Options195.1 K794 K
View Ampio Pharmaceuticals Diagnostics

Selected Ampio Pharmaceuticals Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Ampio Pharmaceuticals Against Markets

Current Ratings

Ampio Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
6 
Chance of
Financial Distress (0 to 100%)
< 66% 
Equity ratings for Ampio Pharmaceuticals are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado. Ampio Pharmaceuticals operates under Biotechnology classification in USA and traded on American Stock Exchange. It employs 17 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAmpio Pharmaceuticals
ChairmanPhilip CoelhoView All
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
LocationCOLORADO, U.S.A
Business Address373 Inverness Parkway
ExchangeAmerican Stock Exchange
CIK Number01411906.0
CUSIP03209T109
SectorHealthcare
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.ampiopharma.com
Contact Number720 437 6500
CurrencyUSD - US Dollar

Did you try this?

Run Coins and Tokens Correlation Now
   

Coins and Tokens Correlation

Utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges
View All  Next Launch Coins and Tokens Correlation

Diversify with Ampio Pharmaceuticals

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Ampio Pharmaceuticals to your portfolio

Executives

Ampio Pharmaceuticals Corporate Executives
Thomas Chilcott Interim CFO
Gregory Gould CFO, Treasurer, Corporate Secretary
Holli Cherevka COO
Check also Trending Equities. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.